Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/2010
09/01/2010CN1523997B Stabilized interleukin 2
09/01/2010CN101821274A Bis(trimethylsilyl)phenyl compound or salt thereof, and use thereof
09/01/2010CN101821229A Tricyclic amine compound
09/01/2010CN101820914A Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient
09/01/2010CN101820882A Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis
09/01/2010CN101820878A Tetrahydroquinoline derivatives for treating post-traumatic stress disorders
09/01/2010CN101820874A Powdered medicament for nasal delivery of ascorbic acid for reducing apomorphine induced toxicity to ciliated tissue
09/01/2010CN101820871A Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine
09/01/2010CN101820868A Novel compounds as cannabinoid receptor ligands
09/01/2010CN101817833A DPP-IV inhibitor
09/01/2010CN101816792A Combinations comprising epothilones and pharmaceutical uses thereof
09/01/2010CN101816775A Chinese medicinal composition for treating renal mass and preparation method thereof
09/01/2010CN101816767A External Chinese medicament for treating goitre
09/01/2010CN101816765A Toxin-expelling and skin-nourishing pill
09/01/2010CN101816721A Chinese medicinal composition for treating children fever caused by exogenous pathogens and preparation method thereof
09/01/2010CN101297860B Chinese medicinal composition for preventing and controlling heat stress and heatstroke of birds
09/01/2010CN101057678B Composition containing natural plant extraction or monomer
08/2010
08/31/2010US7786321 Compounds of the N-acylamino amide family compositions comprising them and uses thereof
08/31/2010US7786311 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
08/31/2010US7786286 Microorganismal, outer-membrane, enzymatic polypeptide for use in developing vaccine for prevention and treatment of nesserial infection
08/31/2010US7786271 Antibodies that inhibit TSLP activity
08/31/2010US7786260 immunogenic; treating or preventing Helicobacter infection in a mammalian host; gastroduodenal disease
08/31/2010US7786177 Phenylalanine enamide derivatives
08/31/2010US7786165 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
08/31/2010US7786140 Piperidine derivative having NMDA receptor antagonistic activity
08/31/2010US7786135 Substituted pyrroline kinase inhibitors
08/31/2010US7786131 Anticancer agents; restenosis; atherosclerosis; skin disorders
08/31/2010US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example
08/31/2010US7786081 Peptide composition
08/31/2010US7786048 Condensed heterocyclic pyrazole derivatives as kinase inhibitors
08/31/2010US7785870 Cell-specific expression/replication vector
08/31/2010US7785838 Variants of mammalian prolactin, prolactin receptor antagonists, and methods of use
08/31/2010US7785835 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring
08/31/2010US7785819 Diagnosis of autoimmune disease; generate solid support, incubate with fluid sample, detect preferential antigens, compare to control, evaluate for autoimmune diseases
08/31/2010US7785804 Mammalian CX3C chemokine antibodies
08/31/2010US7785803 Antibody diagnostic kits and methods of use
08/31/2010US7785791 Polypeptide variants with altered effector function
08/31/2010US7785599 Albumin fusion proteins
08/31/2010CA2549558C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
08/31/2010CA2480427C Novel potassium-dependent sodium-calcium exchanger
08/31/2010CA2447779C Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
08/31/2010CA2397723C Brain, spinal and nerve injury treatment
08/31/2010CA2389545C Chemokine receptor binding heterocyclic compounds
08/31/2010CA2364493C Nitrate esters and their use for neurological conditions
08/31/2010CA2227235C Novel galanthamine derivatives, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing such derivatives
08/26/2010WO2010096394A2 Aldehyde-tagged protein-based drug carriers and methods of use
08/26/2010WO2010095767A1 Pyrimidin-4(3h)-one derivatives
08/26/2010WO2010095766A1 1,4-benzodiazepin-2-on derivatives
08/26/2010WO2010095753A1 Novel compound, phosphorylation inhibitor, insulin resistance improving agent, agent to prevent or to treat diabetes, and screening method
08/26/2010WO2010095741A1 Novel steroid derivative and process for production thereof, and pharmaceutical preparation comprising the novel steroid derivative
08/26/2010WO2010095706A1 Novel anti-inflammatory compounds
08/26/2010WO2010095663A1 Fused heterocyclic ring compound
08/26/2010WO2010095463A1 Immunopotentiating composition and process for producing same
08/26/2010WO2010095462A1 Novel compounds comprising a 3-(5-alkoxypyrimidin-2-yl) pyrimidin-4(3h)-one structure and drugs that comprise same
08/26/2010WO2010094151A1 Disinfectant making air fresh and preparation method and use thereof
08/26/2010WO2010080720A3 Conjugates of a lysosomal enzyme moiety and a water soluble polymer
08/26/2010WO2010060940A3 Hsp90 inhibitors for therapeutic treatment
08/26/2010US20100218266 Methods of identifying and using snail1 inhibitory compounds in chondrodysplasia treatment and preparation of pharmaceutical compositions
08/26/2010US20100216976 Sodium-independent transporter carrying acidic amino acid and its gene
08/26/2010US20100216895 Food grade colouring agent
08/26/2010US20100216890 Disinfectant
08/26/2010US20100216871 Use of compounds having ccr antagonism
08/26/2010US20100216840 Benzimidazolidinone derivatives as muscarinic agents
08/26/2010US20100216818 Inhibitors of Post-Amadori Advanced Glycation End Products
08/26/2010US20100216789 Rho-kinase inhibitors
08/26/2010US20100216787 Thiazole derivative
08/26/2010US20100216743 Therapy-enhancing glucan
08/26/2010US20100216728 New use of specific cyklolignans
08/26/2010US20100216716 Cell-Permeable Peptide Inhibitors Of The JNK Signal Transduction Pathway
08/26/2010US20100215786 Morinda citrifolia enhanced lip treatment
08/26/2010US20100215780 Method for treating onychoschizia
08/26/2010US20100215770 Mixed metal compounds for treatment of hyperphosphataemia
08/26/2010US20100215753 Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
08/26/2010US20100215747 Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
08/26/2010US20100215744 Hydroxypropyl Substitution Used to Regulate Dissolution of a Chemical
08/26/2010US20100215685 Acyl pseudodipeptides which carry a functionalized auxiliary arm
08/26/2010US20100215661 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215652 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215585 Dyes and precursors and conjugates thereof
08/26/2010US20100215583 Cell nucleus-entering compositions
08/26/2010US20100215574 Process for producing an injectable medicament preparation
08/26/2010CA2786891A1 Immunopotentiating composition and process for producing same
08/26/2010CA2752739A1 1,4-benzodiazepin-2-on derivatives
08/26/2010CA2751244A1 Pyrimidin-4(3h)-one derivatives
08/25/2010EP2221377A1 Oligonucleotide compositions with enhanced efficiency
08/25/2010EP2221374A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
08/25/2010EP2221360A1 Lactic acid bacterium having effect of lowering blood uric acid level
08/25/2010EP2221359A1 Lactic acid bacteria having action of lowering blood uric acid level
08/25/2010EP2221308A1 Benzazepinone compound
08/25/2010EP2221307A1 Purine derivatives as adenosine A1 receptor agonists and methods of use thereof
08/25/2010EP2221301A1 Heteroaryloxy quinazoline derivative
08/25/2010EP2221296A1 Fused indane compound
08/25/2010EP2221089A1 Lipoxin analogs as novel inhibitors of angiogenesis
08/25/2010EP2221056A1 Tetracyclines for the treatment of acne
08/25/2010EP2221052A2 Compositions that treat or inhibit pathological conditions associated with inflammatory response
08/25/2010EP2221047A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
08/25/2010EP2220037A1 Synthetic sphingolipid analogs
08/25/2010EP2219636A2 Reduced sexual maturation in fish
08/25/2010EP2219629A1 Novel compounds as cannabinoid receptor ligands
08/25/2010EP2219622A1 Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
1 ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 ... 1564